Overview
Racecadotril has been investigated for the basic science and treatment of Diarrhea, Acute Diarrhea, and Acute Gastroenteritis.
Indication
主要用于腹泻，包括急性腹泻、与人免疫缺陷病毒(HIV)感染或获得性免疫缺陷综合征(艾滋病，AIDS)有关的慢性腹泻，也可与洛哌丁胺合用治疗依立替康所致腹泻。本品静注可用于阿片类物质的戒断症状。
Associated Conditions
- Acute Diarrhea
- Diarrhea
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2024/07/31 | Phase 1 | Not yet recruiting | |||
2024/03/07 | Phase 1 | Not yet recruiting | Pharma Nueva | ||
2022/10/31 | Not Applicable | Recruiting | |||
2022/02/01 | Phase 1 | Completed | |||
2021/05/13 | Not Applicable | UNKNOWN | |||
2018/03/22 | Phase 3 | Completed | |||
2018/03/13 | Phase 3 | Completed | |||
2013/09/23 | Phase 1 | Completed | |||
2012/04/13 | Phase 4 | Completed | Centro Pediatrico Albina de Patino | ||
2011/11/22 | Phase 1 | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| Hidrasec Children Granules for Oral Suspension 30mg | SIN14413P | GRANULE, FOR SUSPENSION | 30.00mg | 9/30/2013 | |
| Hidrasec Infants Granules for Oral Suspension 10mg | SIN14412P | GRANULE, FOR SUSPENSION | 10.00mg | 9/30/2013 |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| No Health Canada approvals found for this drug. | |||||
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| TIORFAN 100 mg CAPSULAS DURAS | Bioprojet Ferrer | 63286 | CÁPSULA DURA | Medicamento Sujeto A Prescripción Médica | Commercialized |
| TIORFAN INFANTIL 4 MG/ML SUSPENSIÓN ORAL | 88685 | SUSPENSIÓN ORAL | Medicamento Sujeto A Prescripción Médica | Not Commercialized | |
| TIORFAN NIÑOS 30 mg GRANULADO PARA SUSPENSION ORAL | Bioprojet Ferrer | 64809 | GRANULADO PARA SUSPENSIÓN ORAL | Medicamento Sujeto A Prescripción Médica | Commercialized |
| TIORFAN NIÑOS 30 mg GRANULADO PARA SUSPENSION ORAL | 5109186 | GRANULADO PARA SUSPENSIÓN ORAL | Medicamento Sujeto A Prescripción Médica | Not Commercialized | |
| TIORFAN 175 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | 83529 | COMPRIMIDO RECUBIERTO CON PELÍCULA | Medicamento Sujeto A Prescripción Médica | Not Commercialized | |
| HIDRASEC 100 MG CAPSULAS DURAS | Bioprojet Ferrer | 77809 | CÁPSULA DURA | Sin Receta | Commercialized |
| TIORFAN LACTANTES 10 mg GRANULADO PARA SUSPENSION ORAL | Bioprojet Ferrer | 64816 | GRANULADO PARA SUSPENSIÓN ORAL | Medicamento Sujeto A Prescripción Médica | Commercialized |
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.